SMEK2 Antibody

What is SMEK2 and why is it important to study?

SMEK2 (also known as PPP4R3B) is a regulatory subunit of the serine/threonine-protein phosphatase 4 (PP4) complex. It plays crucial roles in multiple cellular processes including:

• Regulation of PP4C activity at centrosomal microtubule organizing centers

• DNA repair and cell cycle checkpoint regulation

• Nuclear chaperoning of cleaved Wnt receptor components

• Hepatic glucose production and gluconeogenesis

• Histone deacetylation and transcriptional regulation

• Embryonic stem cell pluripotency and suppression of mesoderm differentiation

The diverse functions of SMEK2 make it a significant target for studies in cellular signaling, metabolism, and developmental biology. Understanding its expression and regulatory mechanisms can provide insights into both normal physiology and pathological conditions.

How do I select the appropriate SMEK2 antibody for my research application?

When selecting a SMEK2 antibody, consider these key factors:

• Application compatibility: Verify the antibody has been validated for your specific application (WB, IHC, ICC/IF, ELISA). For example, the Proteintech antibody (20348-1-AP) is validated for WB, IF, IHC, and ELISA applications .

• Species reactivity: Ensure the antibody recognizes SMEK2 in your experimental species. Available antibodies show reactivity with human, mouse, and rat SMEK2 .

• Epitope location: Consider whether you need an antibody targeting a specific domain. For instance, the Abcam antibody (ab224222) targets amino acids 650-750 of human PPP4R3B .

• Antibody type: Polyclonal antibodies may provide higher sensitivity but potentially lower specificity compared to monoclonal antibodies. Most commercially available SMEK2 antibodies are rabbit polyclonals .

• Validation data: Review experimental validation data provided by manufacturers, including western blot images and immunostaining patterns, to ensure proper recognition of SMEK2 protein.

What are the common applications for SMEK2 antibodies in research?

SMEK2 antibodies are employed in multiple research applications:

Research has employed these methods to study SMEK2 in:

• Neural stem cells and neuronal differentiation

• Hepatic glucose metabolism

• Embryonic stem cell pluripotency

• Nuclear and cytoplasmic functions in various cell types

What are the optimal protocols for SMEK2 immunohistochemistry in different tissue types?

Successful SMEK2 immunohistochemistry requires protocol optimization based on the tissue type:

General Protocol:

• Perform paraffin embedding and sectioning (4-6 μm sections)

• Deparaffinize and rehydrate sections

• Antigen retrieval (critical step - see below)

• Block endogenous peroxidase activity and non-specific binding

• Incubate with primary SMEK2 antibody (typically 1:50-1:100 dilution)

• Apply appropriate detection system and counterstain

Tissue-Specific Considerations:

• Neural tissue: SMEK2 antibodies successfully label both neural stem cells (Nestin-positive) and mature neurons (Map2-positive) in the developing mouse cortex .

• Reproductive tissues: Strong nuclear positivity is observed in glandular cells of human fallopian tube tissue and in seminiferous duct cells of testis tissue using ab224222 at 1:50 dilution .

• Liver tissue: Primarily cytoplasmic staining is observed in hepatocytes .

• Cancer tissues: Nuclear staining is observed in cervical cancer samples using 20348-1-AP at 1:100 dilution .

Critical Parameters:

• Antigen retrieval is essential; heat-induced epitope retrieval in citrate buffer (pH 6.0) is typically effective

• Longer primary antibody incubation (overnight at 4°C) may improve signal-to-noise ratio

• Including positive control tissues with known SMEK2 expression is recommended

How can I optimize western blot protocols for detecting SMEK2 protein?

For optimal SMEK2 detection by western blot:

Sample Preparation:

• Use RIPA buffer supplemented with protease inhibitors for efficient protein extraction

• Include phosphatase inhibitors if studying phosphorylation status

• Sonicate briefly to ensure complete lysis and reduce sample viscosity

Gel Electrophoresis and Transfer:

• Load 20-50 μg total protein per lane

• Use 8-10% acrylamide gels due to SMEK2's size (observed MW: 94-97 kDa, occasionally 87 kDa)

• Transfer to PVDF membrane at lower voltage for longer time (e.g., 30V overnight) to ensure complete transfer of larger proteins

Antibody Incubation:

• Block with 5% non-fat milk or BSA (if phospho-specific detection is needed)

• Incubate with primary antibody at 1:500-1:1000 dilution for higher specificity

• Use gentle rocking at 4°C overnight for optimal binding

• Include longer washing steps (5 × 5 minutes) to reduce background

Detection Considerations:

• SMEK2 may appear as multiple bands due to post-translational modifications or splice variants

• The expected molecular weight is 97 kDa, but observed bands can range from 87-97 kDa

• Validate specificity using positive controls (e.g., HEK-293 cells show good SMEK2 expression)

What approaches can be used to validate SMEK2 antibody specificity?

Rigorous validation is essential for reliable SMEK2 antibody-based experiments:

Genetic Approaches:

• SMEK2 knockdown/knockout: Compare antibody signals in control vs. SMEK2-depleted samples. Research demonstrates effective SMEK2 knockdown using shRNA approaches in hepatocytes and embryonic stem cells .

• Overexpression: Parallel detection of overexpressed tagged SMEK2 using both tag-specific and SMEK2 antibodies.

Biochemical Approaches:

• Peptide competition: Pre-incubate antibody with immunizing peptide to block specific binding.

• Multiple antibody verification: Compare staining patterns using antibodies targeting different SMEK2 epitopes.

• Immunoprecipitation followed by mass spectrometry: Confirm antibody captures SMEK2 protein.

Functional Validation:

• Co-localization: Verify subcellular localization matches known SMEK2 distribution patterns (predominantly cytoplasmic in hepatocytes, nuclear in some cell types) .

• Protein complex detection: Confirm detection of known SMEK2 interactors such as PP4C and PP4R2 by co-immunoprecipitation .

Example Validation Study:
Research has confirmed SMEK1/2 antibody specificity through multiple approaches, including functional effects of knockdown on gluconeogenic gene expression, interaction with known partners (PP4C), and subcellular localization studies in hepatocytes and liver tissue .

How can SMEK2 antibodies be used to investigate its role in the Wnt signaling pathway?

SMEK2 functions as a nuclear chaperone for Wnt receptor components, making antibody-based approaches valuable for studying this pathway:

Co-immunoprecipitation (Co-IP) Studies:

• Use SMEK2 antibodies to precipitate protein complexes from nuclear extracts

• Analyze co-precipitated proteins by western blot for Wnt pathway components

• Research has demonstrated that Smek1/2 associates with Ryk-ICD (intracellular domain) during its nuclear localization

Chromatin Immunoprecipitation (ChIP):

• SMEK2 antibodies can be used for ChIP to identify genomic regions where SMEK2 is recruited

• Follow with qPCR or sequencing to identify Wnt target genes regulated by SMEK2

• This approach helps elucidate SMEK2's role in histone deacetylation and suppression of Wnt-target genes

Immunofluorescence Co-localization:

• Perform dual immunofluorescence with SMEK2 antibodies and antibodies against Wnt pathway components

• Analyze nuclear co-localization during Wnt pathway activation

• Include quantitative co-localization analysis across different cellular compartments

Functional Analysis:
Combine antibody-based detection with functional assays:

• Analyze changes in SMEK2 localization following Wnt pathway stimulation

• Correlate SMEK2 binding to chromatin with changes in histone deacetylation status

• Monitor effects of SMEK2 knockdown on Wnt target gene expression

What techniques can be used to study SMEK2's role in embryonic stem cell pluripotency?

Research has identified SMEK2's critical role in maintaining embryonic stem cell (ESC) pluripotency through suppression of mesoderm differentiation :

Immunofluorescence Analysis:

• Use SMEK2 antibodies to track expression and localization during ESC differentiation

• Co-stain with pluripotency markers (Oct4, Nanog) and lineage markers

• Quantify changes in SMEK2 levels during differentiation using image analysis

Chromatin Immunoprecipitation (ChIP):

• Apply SMEK2 antibodies for ChIP to identify genomic binding sites

• Compare binding profiles in pluripotent vs. differentiating cells

• Integrate with histone modification ChIP data to understand SMEK2's role in epigenetic regulation

Protein Complex Analysis:

• Immunoprecipitate SMEK2 from ESCs at different differentiation stages

• Identify dynamic interaction partners by mass spectrometry

• Validate interactions with co-IP and western blotting

Functional Validation Approaches:

• Create SMEK2 knockdown/knockout ESC lines

• Monitor changes in:

  • Pluripotency marker expression (alkaline phosphatase staining shows reduced pluripotency in Smek1/2 double knockdown ESCs)

  • Differentiation marker expression (Smek1/2 knockdown increases mesoderm markers like brachyury and goosecoid)

  • Formation of embryoid bodies and lineage-specific differentiation

How can immunoprecipitation with SMEK2 antibodies be optimized to study its protein interactions?

Optimizing immunoprecipitation (IP) protocols is critical for studying SMEK2 protein complexes:

Lysis Buffer Optimization:

• For nuclear complexes: Use high-salt nuclear extraction buffers (300-420 mM NaCl)

• For cytoplasmic complexes: Use milder detergents (0.5% NP-40 or 1% Triton X-100)

• Include phosphatase inhibitors to preserve phosphorylation-dependent interactions

• Add protease inhibitors to prevent degradation during extraction

IP Protocol Considerations:

• Pre-clear lysates to reduce non-specific binding

• Use 2-5 μg antibody per mg of protein lysate

• Incubate antibody-lysate mixture overnight at 4°C with gentle rotation

• Use protein A/G magnetic beads for efficient capture

• Include stringent washing steps (at least 4-5 washes)

Specific SMEK2 Complex Detection:
Research has successfully used SMEK2 antibodies to co-immunoprecipitate:

• PP4C and PP4R2 from hepatocytes and mouse liver, confirming formation of a PP4 complex

• Components of the Wnt signaling pathway

Validation Approaches:

• Include IgG controls to identify non-specific binding

• Perform reverse IP with antibodies against suspected interaction partners

• Include knockdown controls to verify specificity of co-precipitated bands

How can I troubleshoot weak or absent signals when using SMEK2 antibodies?

When facing detection issues with SMEK2 antibodies, consider these systematic troubleshooting approaches:

For Western Blot:

• Protein extraction efficiency:

  • Ensure complete cell lysis (sonicate samples briefly)

  • Check protein concentration and loading (increase to 50-75 μg per lane)

  • Verify transfer efficiency using reversible staining of membrane

• Antibody conditions:

  • Increase primary antibody concentration (try 1:250-1:500 dilution)

  • Extend incubation time (overnight at 4°C)

  • Try different antibody clones targeting different epitopes

• Detection sensitivity:

  • Use enhanced chemiluminescence (ECL) substrate with higher sensitivity

  • Consider signal amplification systems

  • Optimize exposure time during imaging

For Immunohistochemistry/Immunofluorescence:

• Antigen retrieval optimization:

  • Test different retrieval methods (heat-induced vs. enzymatic)

  • Extend retrieval time (15-30 minutes)

  • Try different pH buffers (citrate pH 6.0 vs. EDTA pH 9.0)

• Fixation considerations:

  • Excessive fixation may mask epitopes (reduce fixation time)

  • Test different fixatives (PFA vs. ethanol as used in HEK-293 cells)

• Signal amplification:

  • Implement tyramide signal amplification (TSA)

  • Use biotin-streptavidin systems

  • Try polymer-based detection systems

Cell/Tissue-Specific Considerations:

• SMEK2 expression varies across tissues; include positive controls

• Consider subcellular localization (predominantly cytoplasmic in hepatocytes, nuclear in other cell types)

• Check for potential post-translational modifications affecting epitope recognition

What strategies can address non-specific binding of SMEK2 antibodies?

Non-specific binding is a common challenge with antibody-based detection:

For Western Blot:

• Blocking optimization:

  • Test different blocking reagents (5% milk vs. 3-5% BSA)

  • Extend blocking time (2-3 hours at room temperature)

  • Add 0.1-0.3% Tween-20 to washing and antibody dilution buffers

• Antibody dilution optimization:

  • Use more dilute antibody solutions (1:1000-1:3000)

  • Dilute antibodies in blocking buffer with 0.1% Tween-20

  • Pre-adsorb antibody with cell/tissue lysate from a species different from your sample

• Washing stringency:

  • Increase number and duration of washes (5 × 10 minutes)

  • Add higher Tween-20 concentration (0.1-0.3%) in wash buffer

  • Increase salt concentration in wash buffer (up to 500 mM NaCl)

For Immunohistochemistry/Immunofluorescence:

• Block endogenous activities:

  • Include hydrogen peroxide treatment to block endogenous peroxidases

  • Use avidin/biotin blocking for biotin-based detection systems

  • Include mouse IgG blocking when using mouse tissues

• Antibody specificity controls:

  • Include isotype control antibodies

  • Test peptide competition to confirm specific binding

  • Use SMEK2 knockdown samples as negative controls

• Background reduction:

  • Add 0.1-0.3% Triton X-100 to reduce hydrophobic interactions

  • Include 0.1-0.3% BSA in antibody diluent

  • Use filtered antibody solutions to remove aggregates

How do I interpret SMEK2 antibody results when analyzing tissues with varying expression levels?

Interpreting SMEK2 antibody results across different tissues requires careful consideration:

Quantification Approaches:

• Western blot:

  • Use housekeeping proteins appropriate for each tissue type

  • Consider tissue-specific loading controls (e.g., β-actin may vary between tissues)

  • Employ densitometry analysis with multiple technical replicates

• Immunohistochemistry:

  • Use digital image analysis with standard exposure settings

  • Implement H-score or Allred scoring systems for semi-quantitative assessment

  • Include tissue microarrays with multiple samples for standardization

Expression Pattern Interpretation:

• Subcellular localization differences:

  • SMEK2 shows predominantly cytoplasmic localization in hepatocytes

  • Nuclear localization is observed in glandular cells of fallopian tube and seminiferous duct cells

  • Consider functional implications of different localization patterns

• Cell-type specific expression:

  • In neural tissue, SMEK2 is expressed in both neural stem cells (Nestin+) and neurons (Map2+)

  • Different cell types within the same tissue may show varying expression levels

Validation Approaches:

• Multi-method confirmation:

  • Confirm protein expression with both western blot and immunohistochemistry

  • Correlate with mRNA expression (RT-qPCR or RNA-seq data)

  • Use multiple antibodies targeting different epitopes

• Biological context consideration:

  • Interpret results in light of known SMEK2 functions in specific tissues

  • Consider developmental stage or physiological condition

How can SMEK2 antibodies be used to investigate its role in glucose metabolism and potential relevance to metabolic disorders?

Research has identified SMEK2 as a regulator of hepatic glucose production , suggesting applications for metabolic research:

Experimental Approaches:

• Tissue-specific expression analysis:

  • Compare SMEK2 levels in metabolic tissues (liver, muscle, adipose) using western blot and IHC

  • Analyze expression changes in different metabolic states (fed, fasted, insulin-resistant)

  • Correlate with gluconeogenic enzyme expression

• Signaling pathway investigation:

  • Use SMEK2 antibodies for immunoprecipitation to identify metabolic interaction partners

  • Perform proximity ligation assays to detect in situ interactions with CRTC2 and other metabolic regulators

  • Analyze SMEK2 phosphorylation status in different metabolic conditions

• Functional studies:

  • Monitor SMEK2 localization changes during fasting/feeding cycles

  • Analyze SMEK2-dependent changes in gluconeogenic gene promoter occupancy

  • Investigate effects of SMEK2 modulation on glucose production

Research Findings on SMEK2 in Metabolism:

• SMEK2 overexpression promotes higher glucose levels and elevated expression of gluconeogenic genes in mice

• SMEK2 knockdown reduces blood glucose levels and increases hepatic CRTC2 phosphorylation

• SMEK1/2 interact with PP4C and PP4R2 to form a complex in hepatocytes and mouse liver

Translational Applications:

• SMEK2 antibodies can help assess its expression in metabolic disease models and patient samples

• Monitoring SMEK2 levels might serve as a biomarker for hepatic glucose metabolism dysregulation

• Therapeutic targeting of the SMEK2-PP4 pathway could represent a novel approach for metabolic disorders

What are the considerations for using newly developed computational antibody design approaches to generate improved SMEK2 antibodies?

Recent advances in computational antibody design offer opportunities for creating better SMEK2 antibodies:

Deep Learning Approaches for Antibody Design:

• Recent research demonstrates successful antibody design using:

  • Deep learning models trained on antibody sequence and structural data

  • Generative adversarial networks (GANs) to create novel antibody variable regions

  • Combined computational-experimental pipelines for antibody optimization

• Key performance metrics from computational antibody design approaches:

  • 85-89% of computationally designed antibodies successfully express and bind targets

  • High percentage of designed antibodies show improved affinity compared to parent antibodies

  • Generated antibodies exhibit favorable biophysical properties (thermal stability, low hydrophobicity)

Application to SMEK2 Antibody Design:

• Epitope targeting optimization:

  • Design antibodies targeting poorly immunogenic regions of SMEK2

  • Focus on epitopes that distinguish SMEK2 from related family members (SMEK1)

  • Target conformational epitopes for improved specificity

• Species cross-reactivity enhancement:

  • Design antibodies recognizing conserved epitopes across species

  • Optimize for simultaneous reactivity to human, mouse, and rat SMEK2

  • Validate cross-reactivity experimentally across multiple applications

• Application-specific optimization:

  • Design antibodies with properties optimized for specific applications (IHC, IF, IP)

  • Incorporate stability-enhancing modifications for longer shelf-life

  • Engineer reduced non-specific binding

Experimental Validation Requirements:

• Test expression yield and purification efficiency (>90% monomer content is desirable)

• Verify thermal stability (melting temperatures >70°C indicate good stability)

• Assess non-specific binding and self-association propensity

• Validate across multiple applications and cell/tissue types

How can SMEK2 antibodies be integrated with advanced imaging techniques to study its dynamic cellular functions?

Combining SMEK2 antibodies with cutting-edge imaging approaches enables deeper insights into its functional dynamics:

Super-Resolution Microscopy Approaches:

• STED (Stimulated Emission Depletion) microscopy:

  • Use fluorophore-conjugated SMEK2 antibodies for nanoscale resolution imaging

  • Visualize co-localization with interaction partners at subdiffraction resolution

  • Study SMEK2 distribution at centrosomal microtubule organizing centers

• STORM/PALM techniques:

  • Apply single-molecule localization microscopy to map SMEK2 distribution

  • Achieve 20-30 nm resolution to distinguish individual protein complexes

  • Combine with multi-color imaging to visualize multiple components simultaneously

Live-Cell Imaging Strategies:

• Antibody fragment approaches:

  • Generate Fab fragments of SMEK2 antibodies for live-cell applications

  • Conjugate with cell-permeable peptides for intracellular delivery

  • Monitor real-time changes in SMEK2 localization during cell cycle or signaling events

• Intrabody expression:

  • Express single-chain variable fragments (scFvs) derived from SMEK2 antibodies

  • Fuse with fluorescent proteins for live visualization

  • Track SMEK2 dynamics during developmental processes or stress responses

Correlative Light-Electron Microscopy (CLEM):

• Use SMEK2 antibodies for fluorescence imaging to identify regions of interest

• Process the same sample for electron microscopy to obtain ultrastructural context

• Correlate SMEK2 localization with specific subcellular structures at nanometer resolution

Functional Imaging Applications:

• Study SMEK2 recruitment to DNA repair complexes during cell cycle checkpoints

• Visualize dynamic interactions with PP4C at centrosomal structures

• Monitor SMEK2 nuclear-cytoplasmic shuttling during Wnt signaling events

• Track temporal changes in SMEK2 localization during embryonic stem cell differentiation

How should researchers interpret contradictory results obtained with different SMEK2 antibodies?

When faced with discrepancies between different SMEK2 antibody results:

Systematic Analytical Approach:

• Epitope mapping comparison:

  • Identify the target epitopes for each antibody (e.g., Abcam antibody targets aa 650-750)

  • Consider whether epitopes might be differentially accessible in various contexts

  • Check for potential post-translational modifications affecting epitope recognition

• Antibody validation assessment:

  • Review validation data for each antibody (knockout/knockdown controls, peptide competition)

  • Evaluate specificity through western blot band patterns

  • Consider batch-to-batch variability as a potential source of discrepancy

• Experimental condition differences:

  • Compare fixation methods used (PFA vs. ethanol can affect epitope accessibility)

  • Evaluate antigen retrieval approaches (heat-induced vs. enzymatic)

  • Consider differences in detection systems (direct vs. amplified)

Resolution Strategies:

• Multi-antibody validation:

  • Test multiple antibodies against different SMEK2 epitopes in parallel

  • Consider consensus results as more reliable

  • Use genetic approaches (SMEK2 knockdown/knockout) to confirm specificity

• Application-specific optimization:

  • Recognize that antibodies may perform differently across applications

  • Validate each antibody specifically for your application of interest

  • Consider that subcellular localization studies may require different antibodies than protein quantification

• Complementary techniques:

  • Supplement antibody-based detection with mRNA analysis

  • Consider mass spectrometry-based protein identification

  • Implement genetic tagging approaches where feasible

How can researchers integrate SMEK2 antibody data with other omics approaches for comprehensive pathway analysis?

Integrating antibody-based SMEK2 data with multi-omics approaches enhances research depth:

Integration with Transcriptomic Data:

• Correlate SMEK2 protein levels (by western blot) with mRNA expression (RNA-seq or qPCR)

• Analyze transcriptional changes following SMEK2 modulation (overexpression/knockdown)

• Link SMEK2 chromatin occupancy (ChIP-seq) with gene expression data

• Research shows SMEK2 knockdown affects expression of mesoderm markers (brachyury, goosecoid)

Proteomics Integration:

• Combine SMEK2 immunoprecipitation with mass spectrometry to identify interaction partners

• Compare interaction networks across different cellular contexts

• Analyze post-translational modifications of SMEK2 and associated proteins

• Published research demonstrates SMEK2 interactions with PP4C and PP4R2 in liver tissue

Functional Genomics Correlation:

• Integrate CRISPR screening data with SMEK2 antibody-based phenotypic analysis

• Correlate genetic perturbations with changes in SMEK2 localization or complex formation

• Link functional outcomes to pathway activation states

Data Analysis and Visualization Approaches:

• Correlation networks:

  • Build interaction networks centered on SMEK2 and its partners

  • Visualize dynamic changes across experimental conditions

  • Implement weighted gene correlation network analysis (WGCNA)

• Pathway enrichment analysis:

  • Integrate SMEK2 ChIP-seq targets with pathway annotations

  • Analyze enriched pathways among SMEK2-interacting proteins

  • Research shows SMEK2 involvement in Wnt signaling and glucose metabolism pathways

• Multi-omics data integration:

  • Apply dimensionality reduction techniques to visualize data relationships

  • Implement machine learning approaches to identify patterns

  • Develop predictive models of SMEK2 function in specific cellular contexts